FDA approves Biogen’s MS treatment Plegridy for IM administration
Plegridy intramuscular injection offers a treatment option with reduced injection site reactions for individuals with relapsing multiple sclerosis…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Feb 21
Plegridy intramuscular injection offers a treatment option with reduced injection site reactions for individuals with relapsing multiple sclerosis…
01 Feb 21
The vaccine showed 72% effectiveness in the US and an overall 66% effectiveness in preventing Covid-19 after 28…
29 Jan 21
Lilly will be responsible for global development and regulatory activities for AK1780 in the future
28 Jan 21
GSK will transfer the production of the RTS,S antigen to Bharat Biotech, while it will retain the manufacturing…
28 Jan 21
The model avoids patients from exposure to high doses of radiation and nephrotoxic contrast agents
27 Jan 21
AstraZeneca said its Symbicort Turbuhaler is the first approved dual-combination therapy for mild, moderate and severe asthma in…
25 Jan 21
The FDA approval of the combination regimen is based on the results of the phase 3 CheckMate -9ER…
25 Jan 21
Pfizer and BioNTech's Covid-19 vaccine has been provisionally approved for individuals aged 16 years and above
22 Jan 21
ViiV Healthcare said that Cabenuva is the first and only complete long-acting regimen for the treatment of HIV-1…
21 Jan 21
Merck claimed that its Verquvo is the first soluble guanylate cyclase stimulator to receive FDA approval for the…